- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05658354
Cognitive Rehabilitation in People With Metabolic Syndrome and Mild Cognitive Deficits
The goal of this clinical trial is to investigate the possibility of rehabilitation of mild cognitive deficits in people with metabolic syndrome. We aim to implement a cognitive training program on patients with metabolic syndrome and cognitive deficits, and examine its effectiveness both post-intervention (3 months) and after 12 months.
Researchers will compare two groups, the experimental group that will receive the computerized cognitive training and the control group that will receive no training.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ioánnina, Greece, 45110
- Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older
- Presence of metabolic syndrome according to the criteria of IDF (2005) or revised NCEP-ATP III (2005)
- Presence of mild cognitive deficit (-1.5 SD below age and education-adjusted normative mean) in previously administered neuropsychological tests of Trail Making test (Part A & B), Verbal Fluency test (animals and letter "x"), Logical Memory test (immediate and delayed recall)
- Written informed consent to participate
Exclusion Criteria:
- Presence of any serious neurological or psychiatric condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computerized cognitive program
25 participants with metabolic syndrome and mild cognitive deficits; receive health advice using the World Health Organization's guidelines for Risk Reduction of Cognitive Decline and Dementia, and perform the computerized cognitive training program (BrainHQ) for 45 minutes per session, twice per week, over the 3-month intervention period.
|
BrainHQ was developed by Posit Science and includes computer-based brain-training exercises organized into six categories: Attention, Brain Speed, Memory, People Skills, Intelligence, and Navigation.
Participants were instructed to perform a total of 24 sessions of computerized cognitive training at home, consisting of 45 minutes of training, twice per week, over a 3-month period.
|
|
No Intervention: Control group
25 participants with metabolic syndrome and mild cognitive deficits; receive health advice using the World Health Organization's guidelines for Risk Reduction of Cognitive Decline and Dementia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in scores of the Montreal Cognitive Assessment (MoCA) test
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
MoCA is a screening test for mild cognitive dysfunction; range 0-30, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of Complex Figure tests
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
Complex Figures assess visuo-constructional ability and visual memory; range 0-36, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of Hopkins Verbal Learning Test-Revised (HVLT-R)
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
HVLT-R assesses verbal memory using a list of words; range 0-36 (immediate recall) and range 0-12 (delayed recall), higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of Digit Span test
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
Digit Span assesses working memory; range 0-14 (performance) and range 2-9 (span) for forward and backward condition, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of semantic Verbal Fluency test
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
Verbal Fluency assesses executive function that also relies on language component; higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of Flanker task
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
Flanker task assesses executive function and inhibition; range 0-48, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of Continuous Performance Test (CPT)
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
CPT assesses executive function and inhibition; range 0-100, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of Set Shifting
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
Set Shifting assesses executive function and set-shifting; range 0-104, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
|
Change in scores of N-back
Time Frame: baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
N-back assesses working memory; range 0-30, higher scores represent better cognitive function
|
baseline, post-intervention (3 months), follow-up (1 year from baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in scores of Everyday Cognition-II (Ecog-II)
Time Frame: baseline, follow-up (1 year from baseline)
|
Ecog-II is a measure of everyday functioning that includes 41 items to assess memory, language, visual, spatial and perceptual abilities, planning, organization, and divided attention; higher scores represent worse everyday functioning
|
baseline, follow-up (1 year from baseline)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27819
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
University of KhartoumMinistry of Higher Education and Scientific Research, Republic of SudanCompletedMetabolic Syndrome in Postmenopausal FemalesSudan
-
Hacettepe UniversityCompletedMetabolic Syndrome | Metabolic Syndrome Obesity | Metabolic Syndrome ParametersTurkey
-
Universidad de los Andes, ChileCompleted
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Mayo ClinicCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
Clinical Trials on Computerized cognitive program
-
Icahn School of Medicine at Mount SinaiCompleted
-
National Rehabilitation Center, Seoul, KoreaHanyang University; National IT Industry Promotion Agency, Republic of KoreaCompleted
-
Assistance Publique Hopitaux De MarseilleCompletedChildren Born Extremely Premature | Disturbance of Visuo-spatial Working MemoryFrance
-
Human Service Center, IllinoisUnknownMental Disorders | Schizophrenia | Cognitive Symptoms | Vocational RehabilitationUnited States
-
Far Eastern Memorial HospitalCompleted
-
University of BarcelonaUniversity of Pittsburgh; Germans Trias i Pujol Hospital; Fundació La Marató... and other collaboratorsCompleted
-
Universidad de ZaragozaRecruitingCognitive Dysfunction | Mild Cognitive ImpairmentSpain
-
Michigan State UniversityUniversity of Michigan; Global Health Uganda LTDCompleted
-
Stony Brook UniversityNovartisCompletedMultiple Sclerosis | Cognitive Deficits | Gilenya Modifying Therapy for MSUnited States
-
Chinese University of Hong KongCompletedADHD | ASD | Learning DisordersHong Kong